+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Sepsis- Pipeline Insight, 2025 - Product Thumbnail Image

Sepsis- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Endogenous Cushing's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Endogenous Cushing's Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025 - Product Thumbnail Image

Dystrophic Epidermolysis Bullosa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2025 - Product Thumbnail Image

Dry Age-related Macular Degeneration (Dry-AMD)- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Insomnia - Pipeline Insight, 2025 - Product Thumbnail Image

Insomnia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Intracranial Arterial Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Intracranial Arterial Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Irritable Bowel Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Idiopathic Arthritis (JIA) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Juvenile Macular Degeneration - Pipeline Insight, 2025 - Product Thumbnail Image

Juvenile Macular Degeneration - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Kawasaki Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Kawasaki Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Laron Syndrome (LS) - Pipeline Insight, 2025 - Product Thumbnail Image

Laron Syndrome (LS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Late-stage Chronic Kidney Disease (CKD) - Pipeline Insight, 2025 - Product Thumbnail Image

Late-stage Chronic Kidney Disease (CKD) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leigh Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Leigh Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lennox Gastaut Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Lennox Gastaut Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Levodopa-Induced Dyskinesia (LID) - Pipeline Insight, 2025 - Product Thumbnail Image

Levodopa-Induced Dyskinesia (LID) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lice Infestations - Pipeline Insight, 2025 - Product Thumbnail Image

Lice Infestations - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Limb Girdle Muscular Dystrophy - Pipeline Insight, 2025 - Product Thumbnail Image

Limb Girdle Muscular Dystrophy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Coagulation Factor Deficiency - Pipeline Insight, 2025 - Product Thumbnail Image

Coagulation Factor Deficiency - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more